Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 26 citing articles:

The role of extracellular vesicles in circulating tumor cell-mediated distant metastasis
Siyin Guo, Jing Huang, Genpeng Li, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 30
Liquid biopsy in lung cancer
Lan Li, Haixia Jiang, Bingjie Zeng, et al.
Clinica Chimica Acta (2024) Vol. 554, pp. 117757-117757
Closed Access | Times Cited: 14
Tumor‐derived exosomal PD-L1: a new perspective in PD-1/PD-L1 therapy for lung cancer
Yunjiao Wu, Huichao Fu, Jingwei Hao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Extracellular vesicles in cancer: challenges and opportunities for clinical laboratories
Álvaro González, Silvia López-Borrego, Amaia Sandúa, et al.
Critical Reviews in Clinical Laboratory Sciences (2024) Vol. 61, Iss. 6, pp. 435-457
Closed Access | Times Cited: 9
Liquid biopsy technologies: innovations and future directions in breast cancer biomarker detection
L. Cao, Qiaohong Duan, Zixin Zhu, et al.
Biomedical Microdevices (2025) Vol. 27, Iss. 1
Closed Access | Times Cited: 1
Circulating IL6 is involved in the infiltration of M2 macrophages and CD8+ T cells
Jing Huang, Rui Xiao, Songjing Shi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts
Naushad Ahmad Khan, Mohammad Asim, Kabir H. Biswas, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 21
Coaxial dual-path electrochemical biosensing and logic strategy-based detection of lung cancer-derived exosomal PD-L1
J. Liu, Liu Zd, Chunqin Zhao, et al.
Nanoscale (2024) Vol. 16, Iss. 18, pp. 8950-8959
Closed Access | Times Cited: 8
Construction of a sensitive SWCNTs integrated SPR biosensor for detecting PD-L1+ exosomes based on Fe3O4@TiO2 specific enrichment and signal amplification
Hezhen Liu, Yangyang Zhou, Weiwei Chang, et al.
Biosensors and Bioelectronics (2024) Vol. 262, pp. 116527-116527
Closed Access | Times Cited: 7
Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
Dingyu Rao, Defa Huang, Mao-Yan Si, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Proteomic Profiling of Extracellular Vesicles Reveals Potential Biomarkers for Helicobacter pylori Infection and Gastric Cancer
Phawinee Subsomwong, Krisana Asano, Junko Akada, et al.
Helicobacter (2025) Vol. 30, Iss. 2
Open Access
The potential of exosomes in regenerative medicine and in the diagnosis and therapies of neurodegenerative diseases and cancer
Nikola Odehnalová, Viera Šandriková, Róbert Hromádka, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Transcriptomic and proteomic characterization of cell and protein biomarkers of checkpoint inhibitor-induced liver injury
Changhua Ji, Steven W. Kumpf, Jessie Qian, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 6
Open Access
PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways
Jiuling Yang, Li Wang, James R. Byrnes, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 5, pp. 575-591
Open Access | Times Cited: 3
Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapy
Joao Gorgulho, Sven H. Loosen, Ramsha Masood, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
The impact of sarcopenia on the efficacy of PD-1 inhibitors in non-small cell lung cancer and potential strategies to overcome resistance
Zhenchao Liu, Tianxiang Lei, Yunliang Guo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Influencing immunity: role of extracellular vesicles in tumor immune checkpoint dynamics
Ziyang Ye, Genpeng Li, Jianyong Lei
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 11, pp. 2365-2381
Open Access | Times Cited: 2
Mass spectrometry-based proteomic profiling of extracellular vesicle proteins in diabetic and non-diabetic ischemic stroke patients: a case-control study
Shahnaz Qadri, Muhamad Umar Sohail, Naveed Akhtar, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 1
Current status and progress of PD-L1 detection: guiding immunotherapy for non-small cell lung cancer
Chang Qi, Yalun Li, Hao Zeng, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Correlation between exosomal PD-L1 and prognosis in patients with cancer: a systematic review and meta-analysis
Lijun Huang, Qiurong He, Liping Liu, et al.
Clinical & Translational Oncology (2024) Vol. 27, Iss. 3, pp. 1288-1298
Closed Access | Times Cited: 1
Revolutionizing Neuroimmunology: Unraveling Immune Dynamics and Therapeutic Innovations in CNS Disorders
Corneliu Toader, Călin Petru Tătaru, Octavian Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13614-13614
Open Access | Times Cited: 1
Pathological mechanisms of type 1 diabetes in children: investigation of the exosomal protein expression profile
Baoling Bai, Kang Gao, Kexin Zhang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 1
Novel Insights into the Regulation of Exosomal PD-L1 in Cancer: From Generation to Clinical Application
Jie Liu, Junxia Qin, Lili Liang, et al.
European Journal of Pharmacology (2024) Vol. 979, pp. 176831-176831
Closed Access
Overexpression of serum HMGB1 and IDO in esophageal squamous cell carcinoma patients: potential clinical auxiliary diagnostic markers and immunotherapeutic targets
Wenxuan Cui, Yinghao Niu, Xueyuan Zhang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Diagnostic potential and biomarkers potential of exosome nanovesicles
Pushpa Tryphena Kamatham, Rashi Shukla, Prince Giri Goswami, et al.
Elsevier eBooks (2024), pp. 253-284
Closed Access
Page 1 - Next Page

Scroll to top